Ronghua Yang

170 total papers · 5.1k total citations
127 papers, 3.6k citations indexed

About

Ronghua Yang is a scholar working on Molecular Biology, Psychiatry and Mental health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ronghua Yang has authored 127 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 33 papers in Psychiatry and Mental health and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ronghua Yang's work include Migraine and Headache Studies (25 papers), Ferroptosis and cancer prognosis (12 papers) and Wound Healing and Treatments (11 papers). Ronghua Yang is often cited by papers focused on Migraine and Headache Studies (25 papers), Ferroptosis and cancer prognosis (12 papers) and Wound Healing and Treatments (11 papers). Ronghua Yang collaborates with scholars based in China, United States and United Kingdom. Ronghua Yang's co-authors include Melissa Grozinski‐Wolff, Paul Yeung, David W. Dodick, Stephen D. Silberstein, Peter J. Goadsby, Tricia Blankenbiller, Ernesto Aycardi, Yuju Ma, Marcelo E. Bigal and Weihong Tan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

Ronghua Yang

118 papers receiving 3.6k citations

Hit Papers

Fremanezumab for the Prev... 2017 2026 2020 2023 2017 2018 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Fremanezumab for the Preventive Treatment of Chronic Migraine
    2017 542 citations Stephen D. Silberstein, David W. Dodick et al. New England Journal of Medicine profile →
  2. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
    2018 364 citations David W. Dodick, Stephen D. Silberstein et al. JAMA profile →
  3. Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
    2019 268 citations Michel D. Ferrari, Hans‐Christoph Diener et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ronghua Yang 1.5k 1.1k 950 659 304 127 3.6k
Yasemin Özdemir 881 0.6× 1.4k 1.3× 597 0.6× 917 1.4× 316 1.0× 115 5.5k
Basil Sharrack 598 0.4× 1.1k 1.1× 2.1k 2.2× 242 0.4× 328 1.1× 164 5.8k
Robert J. Morgan 697 0.5× 1.7k 1.6× 467 0.5× 246 0.4× 560 1.8× 197 5.8k
Tomás Sobrino 519 0.4× 1.7k 1.6× 284 0.3× 701 1.1× 434 1.4× 203 5.7k
Patrizio Sale 669 0.5× 1.1k 1.0× 255 0.3× 370 0.6× 263 0.9× 104 4.2k
Charles A. Stewart 485 0.3× 1.4k 1.3× 750 0.8× 791 1.2× 179 0.6× 102 6.1k
Kirk W. Johnson 1.6k 1.1× 2.5k 2.4× 966 1.0× 2.1k 3.2× 205 0.7× 135 7.6k
Haruhiko Kikuchi 936 0.6× 1.8k 1.7× 391 0.4× 490 0.7× 262 0.9× 261 8.3k
Yi Yang 263 0.2× 1.2k 1.1× 258 0.3× 581 0.9× 370 1.2× 224 5.0k
Juan Sanchez‐Ramos 508 0.3× 2.8k 2.6× 324 0.3× 759 1.2× 424 1.4× 148 9.6k

Countries citing papers authored by Ronghua Yang

Since Specialization
Citations

This map shows the geographic impact of Ronghua Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronghua Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronghua Yang more than expected).

Fields of papers citing papers by Ronghua Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronghua Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronghua Yang. The network helps show where Ronghua Yang may publish in the future.

Co-authorship network of co-authors of Ronghua Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ronghua Yang. A scholar is included among the top collaborators of Ronghua Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronghua Yang. Ronghua Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen B. Levine Breakdown of academic impact, for papers by Yoshiko Ariji Breakdown of academic impact, for papers by Shin R. Mukai Breakdown of academic impact, for papers by Zhanhuan Shang Breakdown of academic impact, for papers by Sarit K. Das Breakdown of academic impact, for papers by Sébastien Maury Breakdown of academic impact, for papers by David J. Lary Breakdown of academic impact, for papers by M. Heesen
Rankless by CCL
2026